Switch to ADA Accessible Theme
Close Menu
New Jersey Employment Lawyer

New Jersey


New York

New Jersey Employment Lawyers > Blog > New Jersey Injury Attorney > Pradaxa Linked to Heart Attack and Bleeding and Fda Undertakes Safety Review

Pradaxa Linked to Heart Attack and Bleeding and Fda Undertakes Safety Review

Pradaxa® is oral anticoagulant from the class of the direct thrombin inhibitors. It is being studied for various clinical indications and in some cases it offers an alternative to warfarin as the preferred orally administered anticoagulant (“blood thinner”) since it does not require frequent blood tests for international normalized ratio (INR) monitoring while offering similar results in terms of efficacy.  It was developed by Boehringer Ingelheim.  http://www.boehringer-ingelheim.com/

Pradaxa® was approved by the FDA in October 2010 for stroke prevention in patients with atrial fibrillation. It is the first of a new crop of blood clot preventers meant to replace warfarin — a longtime oral treatment that carries serious bleeding risks and requires routine blood monitoring and stringent dietary restrictions.  http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm230241.htm

On Dec. 7, 2011, the U.S. Food and Drug Administration (FDA) announced that it had began a formal investigation into the 260 reports of fatal Pradaxa® injuries that occurred from March 2008 to October 2011.  http://www.fda.gov/drugs/drugsafety/ucm282724.htm

In March 2012, Pradaxa® was linked by the Journal of Neurosurgery to the death of an elderly man who suffered a massive brain hemorrhage after a fall.  It is though that the man hemorraged to death because Praxada prevented blood from clotting.  http://thejns.org/doi/full/10.3171/2012.2.JNS112132?prevSearch=pradaxa&searchHistoryKey=

If you or someone you love has been treated with the anticoagulant medication Pradaxa® (dabigatran) and has suffered a serious side effect such as a heart attack or internal bleeding, a Pradaxa® injury lawsuit may be right for you.  To find out if you qualify to seek compensation for your injuries, please contact us immediately.

Facebook Twitter LinkedIn
Attorney Advertising

The information on this website is for general information purposes only. Nothing on this site should be taken as legal advice for any individual case or situation. This information is not intended to create, and receipt or viewing does not constitute, an attorney-client relationship.

No content on this site may be reused in any fashion without written permission from www.pllawfirm.com

© 2022 - 2024 Poulos LoPiccolo PC. All rights reserved.
This law firm website and legal marketing are managed by MileMark Media.